UGG stivali cnk fwe efso xsn

asbryobvrz · Wysłany: Pią 20:24, 11 Mar 2011

,[link widoczny dla zalogowanych]
Flat condyloma and secondary syphilis-like papules Bowen 1 case of coexistence

Test results in Table I. Table I condyloma in peripheral NK cells and T lymphocyte subpopulations (%) and serum levels of IL-2 (me / m]) (X ± S) test of time a group of 81 patients with two groups of 106 patients before treatment after treatment before treatment after treatment, 4.29 ± 2. Add 48.1 ± 1.8939.1 ± 1.754.39 ± 2.037.1 ± ll839.1 ± 13.147 ± 13.640.1 ± 17.671 ± 6570.1 ± 6.9605 ± 7 .265.1 ± 9.237.2 ± 8.341 ± 10337 ± 8.140 ± 10.534 ± 8.134.1 ± 7535.4 ± 10.134 ± 7.913 ± 0313 ± 0.311 ± 0 .41.1 ± 0.42.2 8l follow-up treatment results for the first time patients were cured, 106 cases of relapse, the second follow-up the first sub-group of 35 patients ① l9 cases of recurrence,[link widoczny dla zalogowanych], the recurrence rate of 55.6%. The first sub-group of 39 patients ② l8 cases of recurrence, the recurrence rate of 46.2%. The first sub-group of 32 patients ③ 7 cases of recurrence, the recurrence rate of 21.8%. Three treatment groups were statistically processing the sub-sub-groups 2,[link widoczny dla zalogowanych],3, s 1,[link widoczny dla zalogowanych],3 subgroup were significantly different,[link widoczny dla zalogowanych], but 1,2 no difference between subgroups. . Table Ⅱ treatment of different CA in the efficacy of treatment n cure cure rate of the first group of sub-Group ① ② ③ Asian Group subgroup 353932l62l2555.6% 46.2% 21.8% by the test, the first ① ② subgroup x0.22P> 0.05; first ② ③ subgroup x3.54P <o. 05; first ① ③ subgroup of a 6.28P <o. 013 187 cases of CA to discuss the cellular immunity in patients with test results (see Table I) can be seen in the two groups were randomly divided into immune function before treatment were significantly different, especially the recurrent group was significantly lower than the cure group C, which scholars believe that the same ... 1. This reflects the impact of immune function is an important factor in the recurrence of CA. Table Ⅱ shows the three treatment subgroups and treatment with interferon dose increased recurrence rate decreased, while cells from the immune function of the last test results to see: With the increase of interferon dose and regimen, further improving immune function, to reflect the interferon can improve immune function, showing that CA recurrence and cellular immune function, interferon treatment, the dose close. Interferon is a biological response modifier drugs, itself has no direct antiviral activity, when it enters cells induced transcription of a kind 1] port Bu mRNA, then it guides the synthesis of , virus replication virus nucleic acid and the synthesis of enzymes needed to make the propagation of the virus play an antiviral effect by inhibiting the same time, it can enhance NK cell function, regulation of cell immune function, when the normal immune function, can play an anti- effects of the virus, and when the body's immune function, the need to increase the cellular immune function, can play an antiviral effect, is dose interferon therapy, the duration of efficacy of treatment-related causes